AI Takeaway
Dow's Q2 2026 net sales rose 20% year-over-year to $12.1 billion driven by higher local prices across all segments, and the company swung to net income of $721 million (EPS $0.99) from a net loss of $835 million (EPS -$1.18) in Q2 2025, aided by Transform to Outperform cost initiatives and reduced restructuring charges.
Filed · Source: SEC EDGAR 10-Q filing
Q2 2026 net sales were $12,092M, up 20% from $10,104M in Q2 2025, driven by local price increases of 20% across all segments (Packaging & Specialty Plastics +30%, Industrial Intermediates & Infrastructure +15%, Performance Materials & Coatings +4%) and a favorable 1% currency impact, partially offset by a 1% volume decline.
Source: 10-Q Item 2 MD&A
Announced in 2026, Transform to Outperform aims to deliver at least $2 billion in near-term Operating EBITDA improvement through cost simplification and growth, accretive to the prior $1 billion structural cost reduction program; the company delivered $190M of Operating EBITDA improvement from this program in the first half of 2026.
Source: 10-Q Item 2 MD&A
Restructuring and asset related charges - net were $503M in Q2 2026 (vs $591M in Q2 2025), including $445M of Transform to Outperform severance charges related to Corporate and $58M of additional 2025 Restructuring Program charges.
Source: 10-Q Item 2 MD&A
Equity in earnings of nonconsolidated affiliates was $36M in Q2 2026 versus a $30M loss in Q2 2025, primarily due to the company's suspension of recognizing its share of equity losses from the Sadara joint venture in 2026; however, six-month equity losses rose to $267M due to a Sadara guarantee liability adjustment.
Source: 10-Q Item 2 MD&A
Geopolitical instability in the Middle East, including the Iran-Israel-U.S. conflict and disruptions to the Strait of Hormuz, has caused volatility in energy/feedstock prices and directly impacted the company's Middle East joint ventures, though Dow's cost-advantaged U.S. & Canada and Latin America operations were not directly affected.
Source: 10-Q Item 2 MD&A
The ongoing conflict involving Iran, Israel, and the United States, and related disruptions to shipping through the Strait of Hormuz, has caused volatility in energy and feedstock prices, longer transit times, and supply constraints particularly in Asia Pacific and Europe. The company's joint ventures located in the Middle East have been directly impacted by the conflict.
Source: 10-Q Item 1A
The U.S. changed long-standing trade policies in 2025, imposing significant new tariffs on virtually all imported goods; while certain tariffs were struck down by the Supreme Court in February 2026, the U.S. subsequently announced additional new tariffs, keeping rates substantially above pre-2025 levels. This ongoing uncertainty could impact sales volume, pricing, production costs, and global supply chains.
Source: 10-Q Item 1A
Increased worldwide competition has resulted in lower prices and lower sales volume in recent periods, negatively impacting results of operations. Long-term market uncertainty, inflationary pressures, and higher input costs have reduced demand for Dow's products and caused supply chain constraints.
Source: 10-Q Item 1A
The Russia-Ukraine conflict, ongoing for over four years, has led to sanctions imposed by the U.S., Canada, the EU and others, causing Dow to cease in-bound investment to Russia. While not currently material, the fluid situation could result in additional sanctions affecting sales, supply chains, foreign exchange volatility, and raw material/energy costs, notably in Europe.
Source: 10-Q Item 1A
Reported EPS of $1.44 versus the $1.29 analyst consensus — a +12.0% beat for Q2 2026.
Expected release date, analyst estimates & what to watch
Dow Inc. reported a deepening net loss of -$533M in Q1 2026, as revenue fell 6.1% YoY to $9.79B amid persistent cost pressures, though operating cash flow surged to $1.12B and the cash position nearly tripled to $4.11B.
DOW's FY2025 10-K reveals a significant deterioration in financial performance, with revenue declining 7.0% to $39.97B and EPS swinging sharply to -$3.70 from +$1.57, reflecting severe margin compression and a dramatic drop in operating cash flow.
The filing does not disclose analyst estimates, but Dow reported net sales of $12.1 billion (up 20% YoY) and swung to net income of $721 million ($0.99 EPS) from a $835 million net loss ($1.18 loss per share) in Q2 2025, a substantial year-over-year improvement.
Net sales grew 20% to $12.1 billion, driven by a 20% increase in local price across all segments and geographies, plus a 1% favorable currency impact, partially offset by a 1% volume decline mainly in Asia Pacific and EMEAI.
Transform to Outperform is a 2026 initiative targeting at least $2 billion in near-term Operating EBITDA improvement through cost simplification and growth actions; Dow delivered $190 million of Operating EBITDA improvement from the program in the first half of 2026, alongside $445 million of related severance charges in Q2 2026.
Dow highlighted the Middle East conflict (Iran-Israel-U.S. tensions disrupting Strait of Hormuz shipping and directly impacting its Middle East joint ventures), evolving and elevated U.S. tariffs on imports, and ongoing Russia-Ukraine conflict sanctions exposure as key company-specific risks.
Cash provided by operating activities from continuing operations was $1,324 million in Q2 2026, an increase of $1,794 million compared to Q2 2025, primarily reflecting improved earnings during the quarter.